Nippon Express Holdings bolsters pharmaceutical logistics quality system globally

KUALA LUMPUR, March 9 (Bernama) -- Tokyo-based Nippon Express Holdings Inc has compiled the NX-Pharma Global Quality Manual to unify and standardise pharmaceutical logistics quality standards on a global basis, applicable as of Jan 1, 2023.

In a statement, it said the Nippon Express Group has positioned the pharmaceutical industry as a key industry in its "Nippon Express Group Business Plan 2023 -- Dynamic Growth" and has acquired Good Distribution Practice, CEIV Pharma and other certifications for pharmaceutical logistics at 34 business locations in 24 countries/regions.

This is to meet increasingly stringent and diverse pharmaceutical logistics needs as the Group develops a safe and secure worldwide pharmaceutical logistics network centred on these certifications.

In addition to further improving the quality of its existing transport, storage and other services, the Group is striving to build a pharmaceutical logistics platform that creates new value.

Furthermore, the Group has established Pharmaceutical Logistics Global Quality Assurance Division within the Global Business Headquarters and appointed the Head of NX-Pharma Global Quality to bolster the quality management system on a global level.

The Nippon Express Group remains committed to providing logistics support to customers in the global pharmaceutical industry by building a reliable and secure global pharmaceutical logistics platform and thereby contributing to the health of people worldwide.

More details at https://www.nipponexpress.com/

-- BERNAMA